What is the dosage of Actimmune?

Actimmune is available in 1 dosages, including 0.2 mg/ml Injection 0.5 ml

What does Actimmune treat?

Actimmune treats Bacterial Infections, Brain Neoplasms, Renal Cell Carcinoma, Cryoglobulinemia, Hepatitis D, Hemangioma, Hepatocellular Carcinoma, Ileal Neoplasms, Hairy Cell Leukemia, Macular Degeneration, Melanoma, Multiple Myeloma, Mycosis Fungoides, Osteopetrosis, Kaposi Sarcoma, Sezary Syndrome, Skin Neoplasms, Skin Ulcer, Essential Thrombocythemia, Thrombocytopenia, Warts, Colorectal Neoplasms, Hypereosinophilic Syndrome and Chronic Hepatitis C

What is Actimmune made of?

Actimmune contains interferon gamma-1b which is a Interferon gamma

How is Actimmune administered?

Actimmune is administered as a Injectable

What is Actimmune mechanism of action?

Actimmune mechanism of action is

Dosage & Administration Drug label Prior authorization Financial assistance

Patient education

Actimmune

(interferon gamma-1b)

0.5 ML interferon gamma-1b 0.2 MG/ML Injection [Actimmune]

NO BLACK BOX WARNING

Dosage & administration

* For subcutaneous use only
* The recommended dose is 50 mcg/m2 for patients whose body surface area is greater than 0.5 m2 and 1.5 mcg/kg/dose for patients whose body surface area is equal to or less than 0.5 m2 three times weekly.
* Monitor hematology, blood chemistries and urinalysis prior to the beginning of treatment and at 3-month intervals.
* If severe reactions occur, reduce dose by 50 percent or discontinue therapy until the adverse reaction abates.

drug label

Actimmune prescribing information

Have more Actimmune questions?

Submit MSL Request

Learn More

Need to report an Actimmune issue?

ONLINE FORMReport adverse event

Learn More

prior authorization

Actimmune Prior authorization resources

NOT PROVIDED BY BRANDComplete Letter of Medical Necessity

NOT PROVIDED BY BRANDCoverage Authorization Request

NOT PROVIDED BY BRANDComplete Coverage Authorization appeals

Coverage Authorization Appeals: Chronic Granulomatous Disease (CGD)

NOT PROVIDED BY BRANDCoverage Authorization Appeals: Severe Malignant Osteopetrosis (SMO)

Letter of Medical Necessity: Chronic Granulomatous Disease (CGD)

Letter of Medical Necessity: Severe Malignant Osteopetrosis (SMO)

PA Checklist

Appeals Checklist

Learn More

Benefits investigation

Actimmune Patient Enrollment & Prescription Form

Learn More

Reimbursement help (FRM)

NOT PROVIDED BY BRANDReimbursement help (FRM) resources

Learn More

financial assistance

Actimmune Financial assistance options

Co-pay savings program

commercial only

Actimmune Patient Enrollment & Prescription Form

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement